508 related articles for article (PubMed ID: 28481356)
21. Hypertrophic Cardiomyopathy: Diverse Pathophysiology Revealed by Genetic Research, Toward Future Therapy.
Hayashi T
Keio J Med; 2020 Dec; 69(4):77-87. PubMed ID: 32224552
[TBL] [Abstract][Full Text] [Related]
22. Mutations in myosin S2 alter cardiac myosin-binding protein-C interaction in hypertrophic cardiomyopathy in a phosphorylation-dependent manner.
Singh RR; McNamara JW; Sadayappan S
J Biol Chem; 2021 Jul; 297(1):100836. PubMed ID: 34051236
[TBL] [Abstract][Full Text] [Related]
23. Myosin binding protein C, a phosphorylation-dependent force regulator in muscle that controls the attachment of myosin heads by its interaction with myosin S2.
Kunst G; Kress KR; Gruen M; Uttenweiler D; Gautel M; Fink RH
Circ Res; 2000 Jan 7-21; 86(1):51-8. PubMed ID: 10625305
[TBL] [Abstract][Full Text] [Related]
24. [Familial hypertrophic cardiomyopathy: genes, mutations and animal models. A review].
Ramírez CD; Padrón R
Invest Clin; 2004 Mar; 45(1):69-99. PubMed ID: 15058760
[TBL] [Abstract][Full Text] [Related]
25. Three perspectives on the molecular basis of hypercontractility caused by hypertrophic cardiomyopathy mutations.
Spudich JA
Pflugers Arch; 2019 May; 471(5):701-717. PubMed ID: 30767072
[TBL] [Abstract][Full Text] [Related]
26. Clinical features, spectrum of causal genetic mutations and outcome of hypertrophic cardiomyopathy in South Africans.
Ntusi NA; Shaboodien G; Badri M; Gumedze F; Mayosi BM
Cardiovasc J Afr; 2016; 27(3):152-158. PubMed ID: 27841901
[TBL] [Abstract][Full Text] [Related]
27. Advances in the Genetic Basis and Pathogenesis of Sarcomere Cardiomyopathies.
Yotti R; Seidman CE; Seidman JG
Annu Rev Genomics Hum Genet; 2019 Aug; 20():129-153. PubMed ID: 30978303
[TBL] [Abstract][Full Text] [Related]
28. Genotype phenotype correlations of cardiac beta-myosin heavy chain mutations in Indian patients with hypertrophic and dilated cardiomyopathy.
Rai TS; Ahmad S; Bahl A; Ahuja M; Ahluwalia TS; Singh B; Talwar KK; Khullar M
Mol Cell Biochem; 2009 Jan; 321(1-2):189-96. PubMed ID: 18953637
[TBL] [Abstract][Full Text] [Related]
29. MYBPC3 truncation mutations enhance actomyosin contractile mechanics in human hypertrophic cardiomyopathy.
O'Leary TS; Snyder J; Sadayappan S; Day SM; Previs MJ
J Mol Cell Cardiol; 2019 Feb; 127():165-173. PubMed ID: 30550750
[TBL] [Abstract][Full Text] [Related]
30. Familial hypertrophic cardiomyopathy: functional effects of myosin mutation R723G in cardiomyocytes.
Kraft T; Witjas-Paalberends ER; Boontje NM; Tripathi S; Brandis A; Montag J; Hodgkinson JL; Francino A; Navarro-Lopez F; Brenner B; Stienen GJ; van der Velden J
J Mol Cell Cardiol; 2013 Apr; 57():13-22. PubMed ID: 23318932
[TBL] [Abstract][Full Text] [Related]
31. Faster cross-bridge detachment and increased tension cost in human hypertrophic cardiomyopathy with the R403Q MYH7 mutation.
Witjas-Paalberends ER; Ferrara C; Scellini B; Piroddi N; Montag J; Tesi C; Stienen GJ; Michels M; Ho CY; Kraft T; Poggesi C; van der Velden J
J Physiol; 2014 Aug; 592(15):3257-72. PubMed ID: 24928957
[TBL] [Abstract][Full Text] [Related]
32. Molecular basis of force-pCa relation in
Yuan CC; Kazmierczak K; Liang J; Ma W; Irving TC; Szczesna-Cordary D
Proc Natl Acad Sci U S A; 2022 Feb; 119(8):. PubMed ID: 35177471
[TBL] [Abstract][Full Text] [Related]
33. Troponin T and beta-myosin mutations have distinct cardiac functional effects in hypertrophic cardiomyopathy patients without hypertrophy.
Revera M; van der Merwe L; Heradien M; Goosen A; Corfield VA; Brink PA; Moolman-Smook JC
Cardiovasc Res; 2008 Mar; 77(4):687-94. PubMed ID: 18029407
[TBL] [Abstract][Full Text] [Related]
34. Properties of mutant contractile proteins that cause hypertrophic cardiomyopathy.
Redwood CS; Moolman-Smook JC; Watkins H
Cardiovasc Res; 1999 Oct; 44(1):20-36. PubMed ID: 10615387
[TBL] [Abstract][Full Text] [Related]
35. The R249Q hypertrophic cardiomyopathy myosin mutation decreases contractility in Drosophila by impeding force production.
Bell KM; Kronert WA; Huang A; Bernstein SI; Swank DM
J Physiol; 2019 May; 597(9):2403-2420. PubMed ID: 30950055
[TBL] [Abstract][Full Text] [Related]
36. Impact of familial hypertrophic cardiomyopathy-linked mutations in the NH2 terminus of the RLC on β-myosin cross-bridge mechanics.
Farman GP; Muthu P; Kazmierczak K; Szczesna-Cordary D; Moore JR
J Appl Physiol (1985); 2014 Dec; 117(12):1471-7. PubMed ID: 25324513
[TBL] [Abstract][Full Text] [Related]
37. Hypertrophic cardiomyopathy β-cardiac myosin mutation (P710R) leads to hypercontractility by disrupting super relaxed state.
Vander Roest AS; Liu C; Morck MM; Kooiker KB; Jung G; Song D; Dawood A; Jhingran A; Pardon G; Ranjbarvaziri S; Fajardo G; Zhao M; Campbell KS; Pruitt BL; Spudich JA; Ruppel KM; Bernstein D
Proc Natl Acad Sci U S A; 2021 Jun; 118(24):. PubMed ID: 34117120
[TBL] [Abstract][Full Text] [Related]
38. In vivo modeling of myosin binding protein C familial hypertrophic cardiomyopathy.
Yang Q; Sanbe A; Osinska H; Hewett TE; Klevitsky R; Robbins J
Circ Res; 1999 Oct; 85(9):841-7. PubMed ID: 10532952
[TBL] [Abstract][Full Text] [Related]
39. Myosin binding protein C positioned to play a key role in regulation of muscle contraction: structure and interactions of domain C1.
Ababou A; Rostkova E; Mistry S; Le Masurier C; Gautel M; Pfuhl M
J Mol Biol; 2008 Dec; 384(3):615-30. PubMed ID: 18926831
[TBL] [Abstract][Full Text] [Related]
40. Screening of MYH7, MYBPC3, and TNNT2 genes in Brazilian patients with hypertrophic cardiomyopathy.
Marsiglia JD; Credidio FL; de Oliveira TG; Reis RF; Antunes Mde O; de Araujo AQ; Pedrosa RP; Barbosa-Ferreira JM; Mady C; Krieger JE; Arteaga-Fernandez E; Pereira Ada C
Am Heart J; 2013 Oct; 166(4):775-82. PubMed ID: 24093860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
